Karo Pharma AB operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Karo Pharma AB with three other
miscellaneous service companies in Europe:
sales of 55.53 million Euro [US$68.22 million]
Basilea Pharmaceutica Limited
(90.67 million Swiss Francs [US$95.25 million]
of which 100%
was Pharmaceutical Products), and
based in Germany
(66.79 million Euro [US$82.05 million]
of which 74%
was Partnered Discovery).
During the year ended December of 2017, sales at
Karo Pharma AB were SEK 657.61 million (US$80.27 million).
increase of 89.4%
versus 2016, when the company's sales were SEK 347.26 million.
This was the third consecutive year of growth at Karo Pharma AB.